Recent pieces address how poor single moms survive, harassment of abortion providers, independence for the elderly, and more.
Yesterday, US Secretary of State John Kerry marked the 10th anniversary of the creation of PEPFAR, the US President’s Plan for Emergency AIDS Relief.
“Pneumocystis Pneumonia — Los Angeles,” in the June 5, 1981 edition of the CDC’s Morbidity and Mortality Weekly Report, was an economical seven paragraph clinical report cataloging five observed cases, accompanied by an explanatory editorial note on the rarity of this fungal disease. It seemed to be nothing out of the ordinary from MMWR, but turned out to be medical literature’s first report of the disease we now know as AIDS.
December 1 was World AIDS Day, and this year’s theme is “Working Together for an AIDS-Free Generation.”
The fact that an International AIDS Conference is happening in the US is a big deal — and the Washington, DC location is meaningful not only because this is the nation’s capital, but because the District has a high rate of HIV infections.
Public Health Practice
June 5, 1981: CDC reports “the possibility of a cellular-immune dysfunction related to a common exposure”
Thirty years ago today, the CDC’s Morbidity and Mortality Weekly Report published a report of five young men with Pneumocystis carinii pneumonia who were treated at three different hospitals in Los Angeles, California. The authors observed that all five patients had no known common contacts, but had in common the fact that they “reported having […]
Today, is World AIDS Day, and while the pandemic continues to devastate millions of lives, we can also honor some achievements. CDC reports that when PEPFAR (the US President’s Plan for AIDS Relief) started in 2003, fewer than 50,000 people in sub-Saharan Africa were getting antiretroviral drugs; now, thanks to a global collaboration, more than […]
In a recent New York Times article, Celia Dugger reports on encouraging results from two studies on interventions that help women in South Africa and Malawi reduce their risk of HIV infection. The first study found that women using a vaginal microbicidal gel were 39% less likely to contract HIV than those using a placebo. […]